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Background: The ataxia telangiectasia-mutated (ATM) gene has a key role in DNA 
repair including activation and stabilization of p53, which implicates the importance of 
ATM polymorphisms in the development of cancer. This study aims to investigate the 
association of two ATM single-nucleotide polymorphisms (SNPs) with lung cancer, as 
well as their potential interaction with p53 gene and other known risk factors of lung 
cancer.
Methods: A population-based case–control study was conducted in Taiyuan city, 
China with 399 cases and 466 controls matched on the distribution of age and sex of 
cases. The two ATM gene SNPs, ATMrs227060 and ATMrs228589 as well as p53 gene 
SNP, p53rs1042522 were genotyped using Sequenom platform. Unconditional logistic 
regression models were used to estimate crude and adjusted odds ratios (aOR) and 95% 
confidence intervals (CIs). Adjusted models controlled for age, sex, and smoking status.
results: The study showed that TT genotype of ATMrs227060 (aOR = 1.58, 95% CI: 
1.06–2.35) and AA genotype of ATMrs228589 were significantly associated with lung 
cancer (aOR =  1.50, 95% CI: 1.08–2.08) in a recessive model. Additionally, carrying 
variant genotypes of ATMrs227060 (TT), ATMrs228589 (AA), and p53rs1042522 (CC) 
concomitantly was associated with much higher risk (aOR = 3.68, 95% CI: 1.43–9.45) 
of lung cancer than carrying variant genotypes of any one of the above three SNPs. We 
also found multiplicative and additive interaction between tea drinking and ATMrs227060 
in association with lung cancer.
conclusion: This study indicates that ATM gene variants might be associated with 
development of lung cancer in Chinese population. These results need to be validated in 
larger and different population samples.
Keywords: lung cancer, ataxia telangiectasia-mutated gene, Dna repair, single-nucleotide polymorphisms, 
chinese population
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inTrODUcTiOn
Lung cancer has been increasing both in incidence and mortality 
in China (1, 2). Smoking and air pollution are major risk factors 
of lung cancer in China. However, the disproportion between 
incidence of lung cancer and prevalence of smoking indicates that 
genetic factors may play an important role in the development of 
lung cancer in Chinese population (3).
The ataxia telangiectasia-mutated (ATM) gene is a Ser/
Thr protein kinase of the phosphoinositidyl 3-kinase family 
located on long arm of chromosome 11q22–q23 (4). It is a key 
gene involved in DNA repair, mainly in double-strand breaks 
(5). It is rapidly recruited to the sites of DNA damage where it 
modulates downstream effectors [e.g., p53, BRCA-1, checkpoint 
kinase 2 (CHK2), RAD50, and NBS1] through phosphorylation 
of protein kinases and substrates. Cells with mutated ATM gene 
lose the ability to cope with genotoxic stresses due to lack of a 
coordinated DNA damage response (DDR) and loss of regulation 
of cell-cycle damage checkpoints (6). The principal component of 
ATM-mediated DDR involves the tumor-suppressor protein p53. 
p53 gene regulates the transcription of other genes responsible for 
cellular antitumor responses such as cell-cycle arrest, apoptosis, 
senescence, genetic stability, and suppression of angiogenesis 
(7). Functional polymorphisms of p53 gene alter protein activity 
and have been shown to be associated with risk of development 
of several human cancers including lung cancer (8–11). ATM 
mediates post-translational modifications of p53 that lead to its 
activation and transcription of genes involved in cell-cycle arrest 
and apoptosis. In addition, modulation of proteins CHK2 and 
MDM2 (which inhibits p53 activation) results in rapid stabiliza-
tion and accumulation of p53 at the DDR sites (12). More recent 
studies suggest a wider role for ATM apart from involvement 
in DDR functions such as response to other forms of genotoxic 
stress like oxidative stress and maintaining cellular homeostasis 
including various cellular signaling pathways, insulin signaling, 
and mitochondrial homeostasis (6, 12, 13). This further indicates 
that polymorphisms of the ATM gene may be involved in cancer 
initiation and progression through multiple pathways.
Ataxia telangiectasia-mutated gene polymorphisms have been 
associated with several cancers including breast, oral, cervical, 
and lung (14–22). Among the ATM single-nucleotide polymor-
phisms (SNPs), we identified two intron variant tagging SNPs with 
r2 > 0.6 and minor allele frequency >5% (MAF), ATMrs227060 
(MAF: 32.3%) and ATMrs228589 (MAF: 46.1%) (23–25). While 
these SNPs showed positive associations with other cancers, 
limited studies examined their association with lung cancer 
with inconsistent results. In previous studies, ATMrs227060 
was positively associated with non-Hodgkin’s lymphoma while 
ATMrs228589 showed positive association with breast cancer in 
Ashkenazi Jewish women as well as chronic myeloid leukemia 
(26–28). In relation to lung cancer, a Caucasian study showed 
positive association of ATMrs227060 with non-small cell lung 
cancer (NSCLC) recent studies in Taiwanese population did not 
find an association of either SNP with lung cancer (15, 22). In the 
current study, we investigated the association of these two ATM 
SNPs with lung cancer in a Chinese population. In addition, we 
explored potential interaction between the ATM gene SNPs and 
the most studied p53 gene SNP, p53rs1042522 in which, Arginine 
(Arg) is substituted by Proline (Pro) at codon 72 (Arg72Pro) 
(29). We also explored potential interaction between the ATM 
SNPs and smoking, alcohol intake, and tea drinking behaviors in 
association with lung cancer.
MaTerials anD MeThODs
study Population
A population-based case–control study was conducted in 
Taiyuan city, the capital of Shanxi Province, China. Incident 
cases were recruited between 2005 and 2007 from Shanxi Tumor 
Hospital, which catered to 70% of all cancer patients in Taiyuan 
city, Shanxi Province, China. Eligibility criteria for cases included 
age 20 years or older, residence in Taiyuan city for 10 years or 
more, medically stable condition and willingness to participate 
in the study. Controls were recruited from 13 randomly selected 
communities in Taiyuan to match cases according to distribu-
tion of age and gender. Eligible controls were aged 20 years or 
older, lived in Taiyuan city for 10  years or more and had no 
history of cancer or any other serious chronic disease. A total of 
399 cases (89% response rate) and 466 controls (85% response 
rate) participated in the study. Detailed methodology for this 
population-based case–control study was previously published 
(30). Half of the participants were males and 56% of participants 
were aged 55 years or older. Around 47% of the participants were 
smokers, 25% of them reported alcohol intake, and 58% of them 
were current tea drinkers.
Data collection
Participants were interviewed face to face by study personnel 
using a structured questionnaire regarding their demographic 
characteristics, smoking, alcohol drinking and tea drinking 
habits, diet during the past 1 year, cooking and indoor heating 
methods, and individual and family medical history. Ever smok-
ers were defined as those with a lifetime exposure of at least 100 
cigarettes.
Biospecimen collection and Processing
Approximately 98% of cases and 99% of controls provided 
peripheral blood samples. Serum and blood clot were separated 
immediately and stored in a −80°C freezer. Genomic DNA 
was isolated for analysis using a modified phenol–chloroform 
method (31).
Primer Design and genotyping
Genotyping for ATM (rs227060 and rs228589) and p53 
(rs1042522) SNPs was performed using Sequenom platform 
(Sequenom, Inc., San Diego, CA, USA) in the Center for 
Genomics and Personalized Medicine Research at Wake Forest 
School of Medicine (Winston-Salem, NC, USA). Polymerase 
chain reaction (PCR) and extension primers were designed 
using MassARRAY Assay Design 3.1 software (Sequenom, Inc., 
San Diego, CA, USA). We followed the manufacturer’s iPLEX 
Application Guide (Sequenom, Inc., San Diego, CA, USA) in 
performing genotyping procedures. PCR reactions were carried 
TaBle 1 | association of ATM gene polymorphisms with lung cancer.
gene genotype cases N (%) controls N (%) crude odds ratio (Or) (95% ci) adjusted odds ratiosa (95% ci)
ATM (rs227060) 352 451
CC 137 (38.9) 183 (40.6) 1.00 1.00
CT 150 (42.6) 213 (47.2) 0.94 (0.69–1.28) 0.93 (0.68–1.28)
TT 65 (18.5) 55 (12.2) 1.58 (1.04–2.41) 1.52 (0.99–2.35)
Dominant model CT + TT 215 (61.1) 268 (59.4) 1.07 (0.81–1.43) 1.06 (0.79–1.42)
Recessive model (ref: CC + CT) TT 65 (18.5) 55 (12.2) 1.63 (1.10–2.41) 1.58 (1.06–2.35)
Allele OR T 1.18 (0.96–1.44) 1.16 (0.94–1.42)
ATM (rs228589) 360 448
TT 103 (28.6) 127 (28.4) 1.00 1.00
TA 150 (41.7) 222 (49.6) 0.83 (0.60–1.16) 0.81 (0.57–1.14)
AA 107 (29.7) 99 (22.0) 1.33 (0.91–1.94) 1.31 (0.89–1.94)
Dominant model TA + AA 257 (71.4) 321 (71.7) 0.99 (0.73–1.34) 0.96 (0.70–1.32)
Recessive model (ref: TT + TA) AA 107 (29.7) 99 (22.0) 1.49 (1.09–2.05) 1.50 (1.08–2.08)
Allele OR A 1.15 (0.95–1.39) 1.14 (0.94–1.38)
Estimates in bold represent statistically significant associations.
aAdjusted for age, sex, and smoking status (0 = never smokers, 1 = ever smokers).
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out in 96-well plates. Two negative control (water) samples and 
two randomly selected replicated samples were randomly plated 
in each plate. The concordance rate (percentages of agreement) 
in quality control pairs was over 99%. Technicians were blinded 
to sample case/control status. The three SNPs conformed to 
Hardy–Weinberg equilibrium.
statistical analysis
We used unconditional logistic regression models to analyze allele 
and genotype associations (in codominant, dominant, and reces-
sive models) of the ATM SNPs with lung cancer by estimating 
crude and adjusted odds ratios (aOR) and 95% confidence intervals 
(CIs). In addition, we estimated crude and adjusted associations 
of risk genotype combinations of ATMrs227060, ATMrs228589, 
and p53rs1042522 with lung cancer. Adjusted models were 
controlled for age, sex, and smoking status (never smokers/ever 
smokers) of the participants. We performed internal validation 
for the genetic effect using a bootstrap method to obtain bias 
corrected estimates based on 1,000 replication data sets created 
by random sampling with replacement. Stratified analyses were 
used to assess the association of the SNPs with lung cancer among 
subgroups of age, sex, smoking, alcohol intake, tea drinking, and 
histological subtypes of lung cancer. For histological subtypes, the 
cases in each subgroup were compared to overall controls. In the 
current study, we assessed additive and multiplicative interaction 
of the each ATM SNP with p53 SNP (gene–gene) as well as with 
other risk factors (gene–environment) like smoking, alcohol 
drinking, and tea drinking exposures. Multiplicative interaction 
was assessed by introducing a product term in logistic regression 
models. Additive interaction was assessed by estimating relative 
excess risk due to interaction (RERI). All analyses were performed 
using SAS 9.3 software. Microsoft Excel was used additionally for 
estimating RERI.
resUlTs
The description of sociodemographic and behavioral charac-
teristics of cases and controls has been presented in detail in a 
previous publication (30). Briefly, a higher proportion of cases 
were heavy smokers and tea non-drinkers. Education level, 
BMI, and average household annual income 10  years prior 
were all higher among controls. Analysis of association of the 
ATM SNPs with lung cancer has been shown in Table  1. The 
frequency of C and T alleles of ATMrs227060 was 64.2 and 35.8% 
in controls and the frequency of T and A alleles ATMrs228589 
was 53.1 and 46.9% in controls, respectively. Lung cancer was 
significantly associated with TT genotype of ATMrs227060 in a 
recessive model (aOR = 1.58, 95% CI: 1.06–2.35). AA genotype of 
ATMrs228589 was also significantly associated with lung cancer 
in a recessive model (aOR = 1.50, 95% CI: 1.08–2.08). Among 
the haplotypes identified from ATMrs227060 and ATMrs228589 
(data not shown), TTAA haplotype was more frequent among 
cases compared to controls but failed to show an association with 
lung cancer (aOR = 1.53, 95% CI: 0.95–1.47). Internal validation 
using a bootstrap procedure with 1,000 replicated data sets con-
firmed the statistically significant association estimates between 
the ATM SNPs and lung cancer (results not shown).
Figure  1 shows the association of ATMrs227060 and 
ATMrs228589 with lung cancer among risk factor subgroups. 
ATMrs227060 (aOR = 2.23, 95% CI: 1.30–3.80) and ATMrs228589 
(aOR = 1.65, 95% CI: 1.07–2.55) showed a significant association 
with lung cancer among tea non-drinkers. Among histological 
subtypes of lung cancer, ATMrs227060 was significantly associ-
ated with small cell carcinoma (SmCC) while ATMrs228589 was 
significantly associated with squamous cell carcinoma (SCC) and 
SmCC.
A previous publication reported the association of p53rs1042522 
SNP with lung cancer (32). Since the role of ATM gene in DNA 
repair closely relates to the function of p53 gene, in the current 
study, we analyzed the association of lung cancer with different 
genotype combinations of ATMrs227060, ATMrs228589, and 
p53rs1042522. The results are presented in Table 2, which shows a 
statistically significant association with lung cancer in presence of 
risk genotypes of all three SNPs (aOR = 3.68, 95% CI = 1.43–9.45). 
Test for linear trend showed statistical significance (ptrend = 0.002). 
Similar to the results in Table  1, internal validation using the 
bootstrap procedure described before confirmed the statistically 
significant associations in Table 2 (results not shown).
FigUre 1 | Forest plots showing the association of ATMrs227060 and ATMrs228589 with lung cancer among different subgroups. Plot shows adjusted 
odds ratios. aAdjusted for age, sex, and smoking status (0 = never smokers, 1 = ever smokers). ca/co, number of cases/controls; AC, adenocarcinoma; SCC, 
squamous cell carcinoma; SmCC, small cell carcinoma. The solid line in the plot represents null value and the broken line represents overall odds ratio (OR). Size of 
the square represents the inverse of the variance of the log OR. ORs in bold represent statistically significant associations.
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TaBle 2 | association of combined genotypes of ATMrs227060, ATMrs228589, and p53rs1042522 with lung cancer.
no. of risk 
genotypes
ATMrs227060 ATMrs228589 p53rs1042522 cases
N (%)
controls
N (%)
crude odds ratio (95% ci) adjusted odds ratiosa (95%ci)
333 441
0 CC + CT TT + TA GG + GC 173 (52.0) 272 (61.7) 1.00 1.00
1 CC + CT AA GG + GC 92 (27.6) 108 (24.5) 1.34 (0.96–1.88) 1.39 (0.98–1.96)
CC + CT TT + TA CC
TT TT + TA GG + GC
2 CC + CT AA CC 53 (15.9) 54 (12.2) 1.54 (1.01–2.36) 1.49 (0.97–2.31)
TT AA GG + GC
TT TT + TA CC
3 TT AA CC 15 (4.5) 7 (1.6) 3.37 (1.35–8.43) 3.68 (1.43–9.45)
p for trend 0.002 0.002
Estimates in bold represent statistically significant associations; p values in bold represent statistically significant linear trend.
aAdjusted for age, sex, and smoking status (0 = never smokers, 1 = ever smokers).
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Based on the results from Table 2, we tested for gene–gene 
interaction between each of the ATM SNPs and the p53 SNP. 
We did not find statistically significant multiplicative or addi-
tive interaction between ATMrs227060–p531042522 and 
ATMrs228589–p531042522 (Table 3). We observed statistically 
significant mul-tiplicative and additive interaction between 
ATMrs227060 and tea drinking but not smoking and alcohol 
drinking in association with lung cancer. Smoking, alcohol 
drinking, or tea drinking did not modify the association between 
ATMrs228589 and lung cancer (Table 3).
DiscUssiOn
In the current study, ATMrs227060 (TT) and ATMrs228589 (AA) 
were positively associated with lung cancer in recessive models. 
In addition, both showed positive association with lung cancer in 
tea non-drinkers and with SmCC subtype. Bonnen et  al. earlier 
reported high linkage disequilibrium (LD) in the ATM gene locus 
(33). We verified this information from publicly available databases 
(HapMap and 1000 Genomes Project) for ATMrs227060 and 
ATMrs228589 (r2 range: 61.9–75.2) (23, 24) in Chinese population 
samples. This may explain the similar associations of the two ATM 
SNPs with lung cancer in our study. Both these SNPs may have 
a role in modifying the ATM gene function and consequently 
altering DNA repair mechanisms. A previous study suggested that 
ATMrs227060 may potentially regulate PI3 kinase activity because 
of its proximity to the ATM PI3 kinase domain (22). Another study 
showed that ATMrs228589 modulates DNA repair capacity of UV 
damaged DNA, which may be due to defects in ATM signaling 
(34). However, it is also possible that these tagging SNPs may not 
be the causal polymorphisms but merely represent other functional 
polymorphisms that are in high LD with the current SNPs [e.g., 
rs189037 (35, 36), rs652311 (15), rs170548 (22), rs664143 (16)].
In the presence of p53rs1042522 variant genotype (CC) 
in addition to variant genotypes of ATMrs227060 (TT) and 
ATMrs228589 (AA), the aOR for developing lung cancer was 
3.68 (95% CI: 1.43–9.45), which was 2.65 times higher than 
with the presence of variant genotype of any one of the three 
SNPs (aOR = 1.39, 95% CI: 0.98–1.96). Analysis for linear trend 
indicated significant gene-dosage effects of the risk genotypes of 
the three SNPs in association with lung cancer. This suggests that 
the risk of development of lung cancer associated with polymor-
phisms in ATM gene variants is much higher in a presence of 
coexisting mutations in the p53 gene.
A recent case–control study in Taiwanese population (358 
cases and 716 controls) examined the association of ATM 
polymorphisms, including ATMrs227060 and ATMrs228589 
with lung cancer. The distribution of variant genotypes among 
controls for both the ATM SNPs [ATMrs227060 (TT: 14.3%) and 
ATMrs228589 (AA: 21.0%)] was similar to the controls in the cur-
rent study [ATMrs227060 (TT: 12.2%) and ATMrs228589 (AA: 
22.0%)]. However, the Taiwanese study did not find a difference 
in proportion of the variant genotypes of either ATMrs227060 
or ATMrs228589 between lung cancer cases and healthy controls 
(15). We are uncertain whether differences in participant selection 
or other additional factors contributed to the variation in findings 
between the two studies. Another study in a Caucasian population 
investigated the association of ATM SNPs with NSCLC (556 cases 
and 556 controls). The allele frequencies of the variant genotypes 
of the two ATM SNPs in the Caucasian study were different from 
the current study [ATMrs227060 (TT: 7.6%) and ATMrs228589 
(AA: 31.5%)]. The Caucasian study reported a significant associa-
tion between ATMrs227060 (C>T) and lung cancer (OR = 1.55, 
95% CI: 1.02–2.35) after controlling for age, gender, and smok-
ing status, which was similar to findings in the current study 
for ATMrs227060 (C>T) (OR =  1.58, 95% CI: 1.06–2.35). No 
significant association was reported for ATMrs228589 in associa-
tion with NSCLC in the Caucasian study (22). All three existing 
studies including the current study that investigated the associa-
tion of the ATM SNPs (rs227060 and rs228589) and lung cancer 
had relatively small sample size. This may have contributed to 
the inconsistency in findings between the studies, requiring 
further evaluation of these associations in larger and different 
populations.
In the stratified analysis, the association between ATMrs227060 
or ATMrs228589 and lung cancer in our study population was 
similar among smokers and non-smokers as evidenced by the 
slightly elevated ORs of similar magnitude in these subgroups. 
These results were different from the Caucasian study, which 
reported a significant association of ATMrs227060 only among 
former smokers (22). In the current study, ATMrs227060 was 
significantly associated with lung cancer among tea non-drinkers 
TaBle 3 | Potential gene–gene and gene–environment interactions of ATM gene polymorphisms in association with lung cancer.
cases
N (%)
controls
N (%)
crude odds ratio (Or) (95% ci) adjusted odds ratiosa (95% ci)
p53rs1042522 ATMrs227060
GG + GC CC + CT 205 (60.1) 310 (70.0) 1.00 1.00
GG + GC TT 44 (12.9) 45 (10.2) 1.48 (0.94 to 2.32) 1.38 (0.87 to 2.19)
CC CC + CT 75 (22.0) 80 (18.0) 1.42 (0.99 to 2.03) 1.44 (1.00 to 2.10)
CC TT 17 (5.0) 8 (1.8) 3.21 (1.36 to 7.58) 3.36 (1.39 to 8.08)
OR for interactionb 1.53 (0.56 to 4.19) 1.68 (0.60 to 4.71)
RERIc 1.32 (−1.49 to 4.12) 1.53 (−1.45 to 4.51)
smoking
Never CC + CT 136 (38.6) 245 (54.3) 1.00 1.00
Never TT 27 (7.7) 31 (6.9) 1.57 (0.90 to 2.74) 1.52 (0.87 to 2.68)
Ever CC + CT 151 (42.9) 151 (33.5) 1.80 (1.32 to 2.45) 3.69 (2.30 to 5.92)
Ever TT 38 (10.8) 24 (5.3) 2.85 (1.64 to 4.96) 6.05 (3.10 to 11.84)
OR for interaction 1.01 (0.46 to 2.22) 1.08 (0.48 to 2.40)
RERI 0.48 (−1.24 to 2.20) 1.84 (−1.63 to 5.32)
alcohol drinking
Never CC + CT 219 (62.2) 295 (65.4) 1.00 1.00
Never TT 46 (13.1) 38 (8.4) 1.63 (1.03 to 2.59) 1.56 (0.97 to 2.51)
Ever CC + CT 68 (19.3) 101 (22.4) 0.91 (0.64 to 1.29) 0.71 (0.47 to 109)
Ever TT 19 (5.4) 17 (3.8) 1.51 (0.77 to 2.96) 1.21 (0.58 to 2.51)
OR for interaction 1.02 (0.43 to 2.40) 1.08 (0.45 to 2.61)
RERI −0.03 (−1.29 to 1.22) −0.07 (−1.17 to 1.04)
Tea drinking
Ever CC + CT 116 (32.9) 170 (37.7) 1.00 1.00
Ever TT 21 (6.0) 29 (6.4) 0.89 (0.43 to 1.87) 0.96 (0.51 to 1.79)
Never CC + CT 171 (48.6) 226 (50.1) 1.37 (0.92 to 2.05) 1.29 (0.90 to 1.86)
Never TT 44 (12.5) 26 (5.8) 2.43 (1.31 to 4.53) 2.89 (1.63 to 5.12)
OR for interaction 2.11 (0.94 to 4.70) 2.32 (1.02 to 5.29)
RERI 1.31 (−0.07 to 2.69) 1.63 (0.05 to 3.21)
p53rs1042522 ATMrs228589
GG + GC TT + TA 180 (51.9) 274 (62.0) 1.00 1.00
GG + GC AA 73 (21.0) 81 (18.3) 1.37 (0.95 to 1.98) 1.35 (0.92 to 1.97)
CC TT + TA 65 (18.7) 71 (16.1) 1.39 (0.95 to 2.05) 1.42 (0.95 to 2.11)
CC AA 29 (8.4) 16 (3.6) 2.76 (1.46 to 5.23) 3.00 (1.55 to 5.83)
OR for interaction 1.44 (0.66 to 3.17) 1.57 (0.70 to 3.55)
RERI 0.99 (−0.81 to 2.80) 1.24 (−0.78 to 3.25)
smoking
Never TT + TA 119 (33.1) 218 (48.7) 1.00 1.00
Never AA 46 (12.8) 59 (13.2) 1.43 (0.92 to 2.23) 1.48 (0.94 to 2.33)
Ever TT + TA 134 (37.2) 131 (29.2) 1.87 (1.35 to 2.60) 4.14 (2.51 to 6.83)
Ever AA 61 (16.9) 40 (8.9) 2.79 (1.77 to 4.41) 6.29 (3.45 to 11.48)
OR for interaction 1.04 (0.55 to 1.99) 1.03 (0.53 to 1.98)
RERI 0.49 (−1.04 to 2.02) 1.67 (−1.27 to 4.61)
alcohol drinking
Never TT + TA 193 (53.6) 257 (57.4) 1.00 1.00
Never AA 79 (21.9) 74 (16.5) 1.42 (0.98 to 2.05) 1.42 (0.97 to 2.09)
Ever TT + TA 60 (16.7) 92 (20.5) 0.87 (0.60 to 1.26) 0.69 (0.44 to 1.08)
Ever AA 28 (7.8) 25 (5.6) 1.49 (0.84 to 2.64) 1.17 (0.62 to 2.21)
OR for interaction 1.21 (0.58 to 2.51) 1.20 (0.57 to 3.53)
RERI 0.20 (−0.77 to 1.18) 0.06 (−0.80 to 0.92)
Tea drinking
Ever TT + TA 116 (32.9) 170 (37.7) 1.00 1.00
Ever AA 21 (6.0) 29 (6.4) 1.44 (0.88 to 2.35) 1.31 (0.79 to 2.17)
Never TT + TA 171 (48.6) 226 (50.1) 1.20 (0.87 to 1.68) 1.37 (0.93 to 2.00)
Never AA 44 (12.5) 26 (5.8) 1.86 (1.19 to 2.91) 2.27 (1.39 to 3.70)
OR for interaction 1.07 (0.56 to 2.04) 1.27 (0.65 to 2.47)
RERI 0.22 (−0.74 to 1.18) 0.59 (−0.49 to 1.68)
Estimates in bold represent statistically significant associations.
aAdjusted for age, sex, and smoking status (0 = never smokers, 1 = ever smokers).
bResults of multiplicative interaction.
cResults of relative excess risk due to interaction. RERI value “0” indicates no biological interaction.
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(aOR = 2.23, 95% CI: 1.30–3.80) but not among tea ever drinkers 
(aOR = 0.95, 95% CI: 0.51–1.78). Tea is a popular beverage in 
China. In our study population, 42% of participants currently/
formerly consumed tea. Tea drinking was found to be significantly 
protective against lung cancer in current drinkers (aOR = 0.54, 
95% CI: 0.37–0.80; results not shown) in our study population. 
The flavins and catechins—mainly epigallocatechin gallate—in 
tea, especially green tea, contribute to its antitumor properties 
such as inhibiting oxidative damage, modulating cell signaling 
pathways to prevent tumorigenesis, and promoting apoptosis and 
cell-cycle arrest in cancer cells (37). In our exploratory interaction 
analysis, we observed statistically significant multiplicative and 
additive interaction between ATMrs227060 and tea drinking in 
association with lung cancer where carrying the variant genotype 
ATMrs227060TT and not consuming tea was associated with a 
higher risk of lung cancer compared to carrying ATMrs227060TT 
or not drinking tea alone. These results suggest that the associa-
tion between ATM SNPs and lung cancer may be modified by tea 
drinking. However, given the small sample size among the tea 
drinking subgroups, the results we observed might be due to 
chance. When stratified by histological type of lung cancer, we 
observed that both ATMrs227060 and ATMrs228589 were sig-
nificantly associated with SCC (a subtype of NSCLC) and SmCC. 
We did not find statistically significant additive or multiplicative 
interaction between the either of the ATM SNPs and smoking or 
alcohol drinking factors.
Ataxia telangiectasia-mutated gene serves as a crucial player 
in DDR mainly by regulating the stabilization and activation of 
p53 (12, 38). Activated p53 modulates the expression of genes 
involved in either activation of cell-cycle checkpoints or apopto-
sis (39). Cell-cycle arrest provides time to repair damaged DNA 
and if the damage is irreparable, p53 promotes apoptosis (12). 
Mutations in the ATM gene could disrupt this finely regulated 
process and cause persistent and unrepaired DNA damage. This 
damage leads to chromosomal aberrations, which increase the 
risk of cancer development. In vitro studies have reported the 
importance of ATM-mediated phosphorylation in IR-induced 
checkpoint activation (40). Previous studies reported higher 
genetic instability and lower ATM protein expression in lung 
cancer patients compared to controls (41). Our results sup-
port the experimental study findings on the role of ATM SNPs 
in development of lung cancer especially in individuals with 
homozygous variant alleles.
A limitation of our study is the relatively small sample size. 
In particular, the association of ATM haplotypes and ATM SNPs 
with lung cancer among risk factor strata may have been affected 
by the smaller subgroup samples and these results should be 
interpreted cautiously. However, the associations that we found 
in our study contribute to the understanding of the potential role 
of ATM gene polymorphisms in the development of lung cancer 
and justify the need to pursue validation in larger studies.
In conclusion, our results indicate that having variant 
genotypes of ATMrs227060 (C>T) and ATMrs228589 (T>A) are 
independently associated with increased risk of developing lung 
cancer in a Chinese population. Further, carriers of variant geno-
types of ATMrs227060, ATMrs228589, and p53rs1042522 (G>C) 
have a significantly increased risk for lung cancer compared to 
carriers of variant genotypes of the SNPs individually.
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